Fortrea Holdings Inc. (NASDAQ:FTRE) Given Consensus Rating of "Hold" by Analysts

Key Points

• Fortrea has a consensus analyst rating of "Hold" from 11 analysts (1 sell, 5 hold, 5 buy) with an average 1-year target of $16.15 and reported price targets ranging roughly $12–$22.
• The company missed expectations on its most recent quarter, reporting EPS of $0.09 vs. $0.16 expected and revenue of $660.5M vs. $665.2M, while showing a negative net margin of 36.21%; the stock trades near $9.63 with a market cap around $900M and a 1‑year range of $3.97–$18.67.
• Insiders sold shares recently (CFO sold 5,061 shares at about $9.07), leaving insiders with 0.38% ownership, even as several institutional investors modestly increased stakes during recent quarters.

Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) has received a consensus recommendation of "Hold" from the eleven analysts that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $16.15.

FTRE has been the subject of several recent research reports. Wedbush set a $21.00 price objective on Fortrea in a research note on Thursday, December 11th. TD Cowen upgraded Fortrea from a "hold" rating to a "buy" rating and set a $15.00 target price for the company in a research note on Monday, March 9th. Citigroup upgraded Fortrea from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $12.00 to $21.00 in a research note on Thursday, December 11th. Truist Financial set a $22.00 target price on Fortrea and gave the company a "buy" rating in a report on Thursday, January 8th. Finally, Barclays dropped their price objective on shares of Fortrea from $15.00 to $12.00 and set an "equal weight" rating on the stock in a research note on Friday, February 27th.

Insiders Place Their Bets

In other Fortrea news, CFO Jill G. Mcconnell sold 5,061 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $9.07, for a total value of $45,903.27. Following the sale, the chief financial officer owned 69,796 shares of the company's stock, valued at approximately $633,049.72. This represents a 6.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 9,673 shares of company stock valued at $92,242 over the last quarter. 0.38% of the stock is currently owned by corporate insiders.

Institutional Trading of Fortrea

Large investors have recently made changes to their positions in the stock. Nisa Investment Advisors LLC boosted its stake in Fortrea by 214.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 3,341 shares of the company's stock worth $28,000 after buying an additional 2,278 shares during the last quarter. Larson Financial Group LLC raised its holdings in shares of Fortrea by 136.7% in the 4th quarter. Larson Financial Group LLC now owns 1,856 shares of the company's stock worth $32,000 after purchasing an additional 1,072 shares during the period. Osaic Holdings Inc. raised its holdings in shares of Fortrea by 74.3% during the 2nd quarter. Osaic Holdings Inc. now owns 6,844 shares of the company's stock valued at $38,000 after buying an additional 2,918 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of Fortrea by 137.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company's stock valued at $43,000 after buying an additional 5,036 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Fortrea by 88.2% during the 3rd quarter. GAMMA Investing LLC now owns 6,043 shares of the company's stock valued at $51,000 after buying an additional 2,832 shares during the period.

Fortrea Stock Performance

NASDAQ FTRE opened at $9.63 on Thursday. The company has a market cap of $900.41 million, a P/E ratio of -0.88, a P/E/G ratio of 0.34 and a beta of 1.80. The company has a debt-to-equity ratio of 1.86, a current ratio of 0.98 and a quick ratio of 0.98. The stock has a 50-day moving average of $10.88 and a two-hundred day moving average of $12.36. Fortrea has a 1-year low of $3.97 and a 1-year high of $18.67.

Fortrea (NASDAQ:FTRE - Get Free Report) last released its earnings results on Thursday, February 26th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.07). The firm had revenue of $660.50 million during the quarter, compared to analyst estimates of $665.22 million. Fortrea had a negative net margin of 36.21% and a positive return on equity of 6.23%. As a group, analysts anticipate that Fortrea will post 0.51 EPS for the current year.

Fortrea Company Profile

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific's Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company's comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea's core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.